share_log
Moomoo 24/7 ·  Apr 9 07:11
Seres Therapeutics Concludes Enrollment In Cohort 2 Of Phase 1B Trial Of SER-155 In Allogeneic Hematopoietic Stem Cell Transplant Patients; Clinical Data Readout Expected End Of Q3 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment